Centene Corp at Barclays Global Healthcare Conference Transcript
I'm Steve Valiquette, the health care services analyst here at Barclays. Welcome to our next session with Centene. With us from the company, we have Sarah London, company's CEO; and also Drew Asher, CFO, as well; and Jen Gilligan from IR in the audience here. So this will be a fireside chat. So I guess with that, we'll just kick right off here. Welcome, first of all.
Thank you.
Questions & Answers
All right. Great. So I guess just starting around the redeterminations. Obviously, that's going to be top of mind for a lot of investors right now. And also, I think, some debate around the overall MLR impact related to redeterminations. I think on the one hand, you have some members enrolled in commercial exchange plans typically generate higher PMPMs and Medicaid members. There's also some
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
